Immunology
Conference Coverage
VIDEO: Treating your atopic dermatitis patients more effectively
Dr. Adam Friedman discusses simple but effective ways to improve treatment of patients with atopic dermatitis at the 2016 ODAC annual meeting.
News
Single and double dose of MenACWY-CRM series are immunogenic
Both single-dose and two-dose meningococcal CRM-conjugate vaccine series (MenACWY-CRM) were immunogenic, but antibody responses were greater in...
News
PPIs caused remission in about half of esophageal eosinophilia cases
About half of patients with symptomatic esophageal eosinophilia achieved complete clinical and histologic remission on proton pump inhibitors,...
News
Reslizumab: FDA panel recommends approval for adults, but not children
An FDA advisory committee voted to approve reslizumab, a Teva-sponsored drug treating severe asthma, for use in patients aged 18 years and older,...
News
EREFS value has diagnostic utility for eosinophilic esophagitis
The Eosinophilic Esophagitis Endoscopic Reference Score, or EREFS, is not only highly predictive of eosinophilic esophagitis but also its...
Conference Coverage
Busting eczema treatment myths: applying the evidence
News
FDA approves mepolizumab for use in combination with other asthma drugs
Nucala (mepolizumab) has been approved for use with other asthma medicines as maintenance therapy for patients aged 12 years and older with a...
Conference Coverage
VIDEO: MMF equals cyclophosphamide’s efficacy in sclerodermal lung disease
Key clinical point: Mycophenolate mofetil controlled scleroderma-induced interstitial lung disease as well as cyclosphosphamide did but with...
News
Off-label prescriptions frequently cause adverse events
Off-label prescribing of drugs is common and very likely to cause adverse events, particularly when no strong scientific evidence supports the off...
Conference Coverage
EADV: Another promising topical for atopic dermatitis
Key clinical point: The pipeline for nonsteroidal topical therapies for pediatric and adult atopic dermatitis shows great promise. Major finding:...